A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond

Scott D. Newsome, Philip J. Aliotta, Jacquelyn Bainbridge, Susan E. Bennett, Gary Cutter, Kaylan Fenton, Fred Lublin, Dorothy Northrop, David Rintell, Bryan D. Walker, Megan Weigel, Kathleen Zackowski, David E. Jones

Research output: Contribution to journalArticle

Abstract

The Consortium of Multiple Sclerosis Centers (CMSC) convened a Framework Taskforce composed of a multidisciplinary group of clinicians and researchers to examine and evaluate the current models of care in multiple sclerosis (MS). The methodology of this project included analysis of a needs assessment survey and an extensive literature review. The outcome of this work is a two-part continuing education series of articles. Part 1, published previously, covered the updated disease phenotypes of MS along with recommendations for the use of disease-modifying therapies. Part 2, presented herein, reviews the variety of symptoms and potential complications of MS. Mobility impairment, spasticity, pain, fatigue, bladder/bowel/sexual dysfunction, cognitive dysfunction, and neuropsychiatric issues are examined, and both pharmacologic and nonpharmacologic interventions are described. Because bladder and bowel symptoms substantially affect health-related quality of life, detailed information about elimination dysfunction is provided. In addition, a detailed discussion about mental health and cognitive dysfunction in people with MS is presented. Part 2 concludes with a focus on the role of rehabilitation in MS. The goal of this work is to facilitate the highest levels of independence or interdependence, function, and quality of life for people with MS.

LanguageEnglish (US)
Pages42-56
Number of pages15
JournalInternational Journal of MS Care
Volume19
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Multiple Sclerosis
Urinary Bladder
Quality of Life
Needs Assessment
Continuing Education
Fatigue
Mental Health
Rehabilitation
Research Personnel
Phenotype
Pain
Cognitive Dysfunction

ASJC Scopus subject areas

  • Clinical Neurology
  • Advanced and Specialized Nursing

Cite this

Newsome, S. D., Aliotta, P. J., Bainbridge, J., Bennett, S. E., Cutter, G., Fenton, K., ... Jones, D. E. (2017). A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond. International Journal of MS Care, 19(1), 42-56. DOI: 10.7224/1537-2073.2016-062

A framework of care in multiple sclerosis, part 2 : Symptomatic care and beyond. / Newsome, Scott D.; Aliotta, Philip J.; Bainbridge, Jacquelyn; Bennett, Susan E.; Cutter, Gary; Fenton, Kaylan; Lublin, Fred; Northrop, Dorothy; Rintell, David; Walker, Bryan D.; Weigel, Megan; Zackowski, Kathleen; Jones, David E.

In: International Journal of MS Care, Vol. 19, No. 1, 2017, p. 42-56.

Research output: Contribution to journalArticle

Newsome, SD, Aliotta, PJ, Bainbridge, J, Bennett, SE, Cutter, G, Fenton, K, Lublin, F, Northrop, D, Rintell, D, Walker, BD, Weigel, M, Zackowski, K & Jones, DE 2017, 'A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond' International Journal of MS Care, vol 19, no. 1, pp. 42-56. DOI: 10.7224/1537-2073.2016-062
Newsome SD, Aliotta PJ, Bainbridge J, Bennett SE, Cutter G, Fenton K et al. A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond. International Journal of MS Care. 2017;19(1):42-56. Available from, DOI: 10.7224/1537-2073.2016-062
Newsome, Scott D. ; Aliotta, Philip J. ; Bainbridge, Jacquelyn ; Bennett, Susan E. ; Cutter, Gary ; Fenton, Kaylan ; Lublin, Fred ; Northrop, Dorothy ; Rintell, David ; Walker, Bryan D. ; Weigel, Megan ; Zackowski, Kathleen ; Jones, David E./ A framework of care in multiple sclerosis, part 2 : Symptomatic care and beyond. In: International Journal of MS Care. 2017 ; Vol. 19, No. 1. pp. 42-56
@article{9dcaf779377d4ecaa41f2238acc6911c,
title = "A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond",
abstract = "The Consortium of Multiple Sclerosis Centers (CMSC) convened a Framework Taskforce composed of a multidisciplinary group of clinicians and researchers to examine and evaluate the current models of care in multiple sclerosis (MS). The methodology of this project included analysis of a needs assessment survey and an extensive literature review. The outcome of this work is a two-part continuing education series of articles. Part 1, published previously, covered the updated disease phenotypes of MS along with recommendations for the use of disease-modifying therapies. Part 2, presented herein, reviews the variety of symptoms and potential complications of MS. Mobility impairment, spasticity, pain, fatigue, bladder/bowel/sexual dysfunction, cognitive dysfunction, and neuropsychiatric issues are examined, and both pharmacologic and nonpharmacologic interventions are described. Because bladder and bowel symptoms substantially affect health-related quality of life, detailed information about elimination dysfunction is provided. In addition, a detailed discussion about mental health and cognitive dysfunction in people with MS is presented. Part 2 concludes with a focus on the role of rehabilitation in MS. The goal of this work is to facilitate the highest levels of independence or interdependence, function, and quality of life for people with MS.",
author = "Newsome, {Scott D.} and Aliotta, {Philip J.} and Jacquelyn Bainbridge and Bennett, {Susan E.} and Gary Cutter and Kaylan Fenton and Fred Lublin and Dorothy Northrop and David Rintell and Walker, {Bryan D.} and Megan Weigel and Kathleen Zackowski and Jones, {David E.}",
year = "2017",
doi = "10.7224/1537-2073.2016-062",
language = "English (US)",
volume = "19",
pages = "42--56",
journal = "International Journal of MS Care",
issn = "1537-2073",
publisher = "Consortium of Multiple Sclerosis Centers (CMSC)",
number = "1",

}

TY - JOUR

T1 - A framework of care in multiple sclerosis, part 2

T2 - International Journal of MS Care

AU - Newsome,Scott D.

AU - Aliotta,Philip J.

AU - Bainbridge,Jacquelyn

AU - Bennett,Susan E.

AU - Cutter,Gary

AU - Fenton,Kaylan

AU - Lublin,Fred

AU - Northrop,Dorothy

AU - Rintell,David

AU - Walker,Bryan D.

AU - Weigel,Megan

AU - Zackowski,Kathleen

AU - Jones,David E.

PY - 2017

Y1 - 2017

N2 - The Consortium of Multiple Sclerosis Centers (CMSC) convened a Framework Taskforce composed of a multidisciplinary group of clinicians and researchers to examine and evaluate the current models of care in multiple sclerosis (MS). The methodology of this project included analysis of a needs assessment survey and an extensive literature review. The outcome of this work is a two-part continuing education series of articles. Part 1, published previously, covered the updated disease phenotypes of MS along with recommendations for the use of disease-modifying therapies. Part 2, presented herein, reviews the variety of symptoms and potential complications of MS. Mobility impairment, spasticity, pain, fatigue, bladder/bowel/sexual dysfunction, cognitive dysfunction, and neuropsychiatric issues are examined, and both pharmacologic and nonpharmacologic interventions are described. Because bladder and bowel symptoms substantially affect health-related quality of life, detailed information about elimination dysfunction is provided. In addition, a detailed discussion about mental health and cognitive dysfunction in people with MS is presented. Part 2 concludes with a focus on the role of rehabilitation in MS. The goal of this work is to facilitate the highest levels of independence or interdependence, function, and quality of life for people with MS.

AB - The Consortium of Multiple Sclerosis Centers (CMSC) convened a Framework Taskforce composed of a multidisciplinary group of clinicians and researchers to examine and evaluate the current models of care in multiple sclerosis (MS). The methodology of this project included analysis of a needs assessment survey and an extensive literature review. The outcome of this work is a two-part continuing education series of articles. Part 1, published previously, covered the updated disease phenotypes of MS along with recommendations for the use of disease-modifying therapies. Part 2, presented herein, reviews the variety of symptoms and potential complications of MS. Mobility impairment, spasticity, pain, fatigue, bladder/bowel/sexual dysfunction, cognitive dysfunction, and neuropsychiatric issues are examined, and both pharmacologic and nonpharmacologic interventions are described. Because bladder and bowel symptoms substantially affect health-related quality of life, detailed information about elimination dysfunction is provided. In addition, a detailed discussion about mental health and cognitive dysfunction in people with MS is presented. Part 2 concludes with a focus on the role of rehabilitation in MS. The goal of this work is to facilitate the highest levels of independence or interdependence, function, and quality of life for people with MS.

UR - http://www.scopus.com/inward/record.url?scp=85013226688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013226688&partnerID=8YFLogxK

U2 - 10.7224/1537-2073.2016-062

DO - 10.7224/1537-2073.2016-062

M3 - Article

VL - 19

SP - 42

EP - 56

JO - International Journal of MS Care

JF - International Journal of MS Care

SN - 1537-2073

IS - 1

ER -